Preclinical in vitro and in vivo evidence for targeting CD74 as an effective treatment strategy for cutaneous T-cell lymphomas.
Saved in:
| Title: | Preclinical in vitro and in vivo evidence for targeting CD74 as an effective treatment strategy for cutaneous T-cell lymphomas. |
|---|---|
| Authors: | Costanza M; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, Berlin, Germany.; Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Giordano C, von Brünneck AC, Zhao J, Makky A, Vinh K, Montes-Mojarro IA, Reisinger F, Forchhammer S; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Witalisz-Siepracka A, Edtmayer S, Stoiber D, Yin G, Horst D; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Fischer A, Siebert R, Nicolay JP; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Yin M; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Janz M; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, Berlin, Germany.; Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Fend F; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Becker JC; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Schürch CM; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Kenner L, Assaf C, Merkel O, Mathas S; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, Berlin, Germany.; Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. |
| Source: | The British journal of dermatology [Br J Dermatol] 2025 Apr 28; Vol. 192 (5), pp. 883-895. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2133 |
|---|---|
| DOI: | 10.1093/bjd/ljaf001 |
